Literature DB >> 19685030

Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.

Tobias Bölling1, Uta Dirksen, Andreas Ranft, Iris Ernst, Heribert Jürgens, Normann Willich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19685030     DOI： 10.1007/s00066-009-1009-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  German register for detection of late sequelae after radiotherapy for children and adolescents (RiSK): present status and first results.

Authors:  Tobias Bölling; Andreas Schuck; Hildegard Pape; Christian Rübe; Frank-Michael Meyer; Carmen Martini; Beate Timmermann; Branka Asadpour; Rolf-Dieter Kortmann; Jörn D Beck; Thorsten Langer; Marios Paulides; Normann Willich
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

2.  Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: a review of the literature and implications for practice.

Authors:  B M Seddon; A M Cassoni; M J Galloway; J H Rees; J S Whelan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-08       Impact factor: 4.126

3.  Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

Authors:  Odile Oberlin; Annie Rey; Anne Sophie Desfachelles; Thierry Philip; Dominique Plantaz; Claudine Schmitt; Emmanuel Plouvier; Odile Lejars; Hervé Rubie; Philippe Terrier; Jean Michon
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

Review 4.  Late effects of thoracic irradiation in children.

Authors:  Tobias Bölling; Stefan Könemann; Iris Ernst; Normann Willich
Journal:  Strahlenther Onkol       Date:  2008-06       Impact factor: 3.621

5.  [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].

Authors:  Christian Ullmann; Jörn-Dirk Beck; Wolfgang Holter; Sabrina Petsch; Jürgen Dunst; Rolf Sauer; Gerhard G Grabenbauer
Journal:  Strahlenther Onkol       Date:  2008-03       Impact factor: 3.621

6.  Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial.

Authors:  Tobias Bölling; Andreas Schuck; Michael Paulussen; Uta Dirksen; Andreas Ranft; Stefan Könemann; Jürgen Dunst; Normann Willich; Heribert Jürgens
Journal:  Strahlenther Onkol       Date:  2008-04       Impact factor: 3.621

7.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials.

Authors:  Andreas Schuck; Susanne Ahrens; Michael Paulussen; Michaela Kuhlen; Stefan Könemann; Christian Rübe; Winfried Winkelmann; Rainer Kotz; Jürgen Dunst; Normann Willich; Heribert Jürgens
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038
  7 in total
  4 in total

1.  A new modification of combining vacuum therapy and brachytherapy in large subfascial soft -tissue sarcomas of the extremities.

Authors:  Maximilian Rudert; Cornelia Winkler; Boris Michael Holzapfel; Hans Rechl; Peter Kneschaurek; Reiner Gradinger; Michael Molls; Barbara Röper
Journal:  Strahlenther Onkol       Date:  2010-03-26       Impact factor: 3.621

2.  Correlation of patient-related factors and dose-volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer.

Authors:  Falk Roeder; Jochen Friedrich; Carmen Timke; Jutta Kappes; Peter Huber; Robert Krempien; Juergen Debus; Marc Bischof
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

3.  High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Authors:  Uta Dirksen; Bernadette Brennan; Marie-Cécile Le Deley; Nathalie Cozic; Henk van den Berg; Vivek Bhadri; Bénédicte Brichard; Line Claude; Alan Craft; Susanne Amler; Natalie Gaspar; Hans Gelderblom; Robert Goldsby; Richard Gorlick; Holcombe E Grier; Jean-Marc Guinbretiere; Peter Hauser; Lars Hjorth; Katherine Janeway; Heribert Juergens; Ian Judson; Mark Krailo; Jarmila Kruseova; Thomas Kuehne; Ruth Ladenstein; Cyril Lervat; Stephen L Lessnick; Ian Lewis; Claude Linassier; Perrine Marec-Berard; Neyssa Marina; Bruce Morland; Hélène Pacquement; Michael Paulussen; R Lor Randall; Andreas Ranft; Gwénaël Le Teuff; Keith Wheatley; Jeremy Whelan; Richard Womer; Odile Oberlin; Douglas S Hawkins
Journal:  J Clin Oncol       Date:  2019-09-25       Impact factor: 50.717

4.  Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.

Authors:  Danny Jazmati; Sarina Butzer; Barbara Hero; Dalia Ahmad Khalil; Julien Merta; Christian Bäumer; Gina Plum; Jörg Fuchs; Friederike Koerber; Theresa Steinmeier; Sarah Peters; Jerome Doyen; Theresa Thole; Matthias Schmidt; Christoph Blase; Stephan Tippelt; Angelika Eggert; Rudolf Schwarz; Thorsten Simon; Beate Timmermann
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.